UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?

Cancer research (Chicago, Ill.), 2013-12, Vol.73 (23), p.6848-6855

2013

Volltextzugriff (PDF)

Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo

Cancer letters, 2017-01, Vol.385, p.179-187

2017

Volltextzugriff (PDF)

Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma

Journal of investigative dermatology, 2015-10, Vol.135 (10), p.2475-2483

2015

Volltextzugriff (PDF)

Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells

Journal of proteome research, 2014-11, Vol.13 (11), p.5041

2014

Volltextzugriff (PDF)

Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells

Journal of investigative dermatology, 2016-10, Vol.136 (10), p.2041-2048

2016

Volltextzugriff (PDF)

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAFV600E Mutant Melanoma Cells

Journal of proteome research, 2014-11, Vol.13 (11), p.5041-5050

2014

Volltextzugriff (PDF)

Abstract 4778: Development of self-amplifying RNA vaccines targeting prostate tissue-restricted and tumor-associated antigens

Cancer research (Chicago, Ill.), 2024-03, Vol.84 (6_Supplement), p.4778-4778

2024

Volltextzugriff (PDF)

Abstract 4543: Identification of downstream targets of polo-like kinase 1 in melanoma by large-scale label-free comparative proteomics profiling

Cancer research (Chicago, Ill.), 2014-10, Vol.74 (19_Supplement), p.4543-4543

2014

Volltextzugriff (PDF)

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF V600E Mutant Melanoma Cells

Journal of proteome research, 2014-11, Vol.13 (11), p.5041-5050

2014

Volltextzugriff (PDF)

Abstract 1920: Small molecule inhibitor of polo-like kinase 1 (Plk1) causes significant melanoma growth delay and regression in vivo

Cancer research (Chicago, Ill.), 2012-04, Vol.72 (8_Supplement), p.1920-1920

2012

Volltextzugriff (PDF)

Polo-like kinase 1 as a therapeutic target in melanoma

Cholewa, Brian D

2014

Volltextzugriff (PDF)

Evaluating opportunities for advancing the use of alternative methods in risk assessment through the development of fit-for-purpose in vitro assays

Toxicology in vitro, 2018-04, Vol.48, p.310-317

2018

Volltextzugriff (PDF)

Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system

Toxicology in vitro, 2019-02, Vol.54, p.41-57

2019

Volltextzugriff (PDF)

Role of the renin-angiotensin system during alterations of sodium intake in conscious mice

American journal of physiology. Regulatory, integrative and comparative physiology, 2001-09, Vol.281 (3), p.987-R993

2001

Volltextzugriff (PDF)

Assessing Bioactivity-Exposure Profiles of Fruits and Vegetables in the BioMAP Profiling System

Toxicology in vitro, 2018-09, Vol.54, p.41-57

2018

Volltextzugriff (PDF)

Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice

Experimental physiology, 2005-07, Vol.90 (4), p.607-612

2005

Volltextzugriff (PDF)

Characterization of L-arginine transporters in rat renal inner medullary collecting duct

American journal of physiology. Regulatory, integrative and comparative physiology, 2000-06, Vol.278 (6), p.1506-R1512

2000

Volltextzugriff (PDF)

Characterization of L-arginine transporters in rat renal inner medullary collecting duct

American journal of physiology. Regulatory, integrative and comparative physiology, 2000-06, Vol.47 (6), p.R1506-R1512

2000

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(20)
Mit Volltextzugriff
(19)

Publikationsform

Artikel
(20)
Dissertationen
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(10)
Science & Technology
(10)
Animals
(7)
Humans
(7)
Polo-Like Kinase 1
(4)
Skin Neoplasms - Pathology
(4)
Cell Cycle Proteins - Metabolism
(3)
Male
(3)
Melanoma - Pathology
(3)
Mice
(3)
Mutation
(3)
Physiology
(3)
Protein Kinase Inhibitors - Pharmacology
(3)
Protein Serine-Threonine Kinases - Metabolism
(3)
Proto-Oncogene Proteins - Metabolism
(3)
Toxicity
(3)
Toxicology
(3)
Aerosols
(2)
Angiotensin Converting Enzyme
(2)
Angiotensin Ii - Blood
(2)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

The Role of Polo-like Kinase 1 in Carcinogenesis: Cause or Consequence?

Small molecule inhibition of polo-like kinase 1 by volasertib (BI 6727) causes significant melanoma growth delay and regression in vivo

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer

Combined Inhibition of MEK and Plk1 Has Synergistic Antitumor Activity in NRAS Mutant Melanoma

Large-scale label-free comparative proteomics analysis of polo-like kinase 1 inhibition via the small-molecule inhibitor BI 6727 (Volasertib) in BRAF(V600E) mutant melanoma cells

Phosphoproteomic Analyses of NRAS(G12) and NRAS(Q61) Mutant Melanocytes Reveal Increased CK2α Kinase Levels in NRAS(Q61) Mutant Cells

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAFV600E Mutant Melanoma Cells

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2

Abstract 4778: Development of self-amplifying RNA vaccines targeting prostate tissue-restricted and tumor-associated antigens

Abstract 4543: Identification of downstream targets of polo-like kinase 1 in melanoma by large-scale label-free comparative proteomics profiling

Large-Scale Label-Free Comparative Proteomics Analysis of Polo-Like Kinase 1 Inhibition via the Small-Molecule Inhibitor BI 6727 (Volasertib) in BRAF V600E Mutant Melanoma Cells

Abstract 1920: Small molecule inhibitor of polo-like kinase 1 (Plk1) causes significant melanoma growth delay and regression in vivo

Development of an aerosol intervention for COVID-19 disease: Tolerability of soluble ACE2 (APN01) administered via nebulizer

Polo-like kinase 1 as a therapeutic target in melanoma

Evaluating opportunities for advancing the use of alternative methods in risk assessment through the development of fit-for-purpose in vitro assays

Assessing bioactivity-exposure profiles of fruit and vegetable extracts in the BioMAP profiling system

Role of the renin-angiotensin system during alterations of sodium intake in conscious mice

Assessing Bioactivity-Exposure Profiles of Fruits and Vegetables in the BioMAP Profiling System

Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice

Characterization of L-arginine transporters in rat renal inner medullary collecting duct

Characterization of L-arginine transporters in rat renal inner medullary collecting duct

Suchergebnisse filtern